Healthcare

Fertility Services Market

By Segment, By Region, And Segment Forecasts, 2016 – 2025

Vertical: HealthcareBase Year: 201811 Sections

Executive Summary

Fertility Services Market — Snapshot

  • Market Size (2016)

    2016

    $20.71B

  • Projected (2025)

    2025

    $44.14B

  • CAGR (2016–2025)

    8.8%

    8.8%
  • Key Players

    108+

Fertility services are procedures or treatments used to cure genetic and fertility issues and assist with conception. These services include assisted reproductive technology (ART) methods and drugs that help single parents, infertile couples and the Lesbian, gay, bisexual, and transgender (LGBT) community in planning a family.

Key factors such as declining fertility rate, technological advancements in fertility treatments, growth in the median age of first-time motherhood, and rise in obesity, along with consumption of alcohol/cigarettes, are leading to infertility which is eventually driving the market for fertility services. However, high procedural costs of assisted reproductive techniques in developed markets and ethical & social concerns related to ART treatment are hampering the overall growth of the fertility services market. Likewise, reimbursement for fertility treatment serves as an opportunity for the growth of the market.

Key Insight

The Fertility Services Market market is projected to grow at a CAGR of 8.8% from 2016 to 2025.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 5 regions: Middle East and Africa, North America, Asia Pacific, Europe, South America.
  • Market Segmentation: The market is analyzed across 2 segments: Female Infertility, Male Infertility. Forecasts are provided for each segment from 2016 to 2025.
  • Competitive Landscape: 108 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Fertility Services Market — Growth Trajectory

The scope of the global fertility services market study includes market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on underlying issue, treatment type, and region.

Fertility Services Market — Growth Trajectory

Female Infertility
Male Infertility

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • Underlying Cause Underlying Cause is broken down into: Female Infertility, Male Infertility.
  • Treatment Type Treatment Type is broken down into: ART, Infertility Drugs.

Geographic Analysis

Regional market breakdown

  • Middle East and Africa Middle East and Africa market size reached $2.15B in 2016 and is projected to reach $3.15B by 2025, growing at a CAGR of 4.3%.
  • North America North America market size reached $4.58B in 2016 and is projected to reach $10.48B by 2025, growing at a CAGR of 9.6%.
  • Asia Pacific Asia Pacific market size reached $5.29B in 2016 and is projected to reach $11.80B by 2025, growing at a CAGR of 9.3%.
  • Europe Europe market size reached $7.12B in 2016 and is projected to reach $15.74B by 2025, growing at a CAGR of 9.2%.
  • South America South America market size reached $1.57B in 2016 and is projected to reach $2.97B by 2025, growing at a CAGR of 7.4%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Fertility Services Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2018

  • Historical Period

    2016 – 2018

  • Forecast Period

    2018 – 2025

  • Primary Interviews

    150+

Research Process

Historical data (2016–2018) and forecast period (2018–2025)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)
Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Fertility Services Market — Competitive Analysis

Threat of New Entrants

The threat of new entrants is low in the global fertility services market. Any fertility drug or device manufacturing company or fertility services providers trying to enter the market is required to accept or abide by the mandatory regulatory standards. This market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for newcomers.

Bargaining Power of Suppliers

In the global fertility services market, suppliers are raw materials manufacturers for drug or device manufacturing companies. The bargaining power of suppliers is low as there is a high number of suppliers in the fertility services market. Additionally, the switching cost is low as no supplier can influence the prices and exercise control in the industry which makes the bargaining power low.

Threat of Substitutes

The threat of substitutes in the global fertility services market is moderate due to the presence of substitutes such as surrogacy and adoption. However, quality and trust issues for the products and services provided by the players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent.

Bargaining Power of Buyers

The bargaining power of buyers is moderate in the global fertility services market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising prevalence rate of infertility. Additionally, the presence of providers is also growing, which makes the bargaining power of buyers moderate due to the low switching costs.

Intensity of Rivalry

The degree of competition in the global fertility services market is high. The restrained degree of product and service differentiation among existing players increases the intensity of rivalry in the market. Fertility service provider companies are trying to provide cost-effective services to make them more affordable. To overcome the competition, drug and device manufacturing players are engaged in developing a process to lower their manufacturing costs.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Fertility Services Market.

Regional Market Size (USD Mn)

Market estimates by geography (2025)

USD Mn

InsightEurope leads with $15.74B by 2025, while North America is projected to grow fastest at a 9.6% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION201620182025CAGRSHARE
Middle East and Africa$2.15B$2.68B$3.15B4.3%7%
North America$4.58B$7.17B$10.48B9.6%24%
Asia Pacific$5.29B$8.18B$11.80B9.3%27%
Europe$7.12B$10.95B$15.74B9.2%36%
South America$1.57B$2.22B$2.97B7.4%7%
Total$20.71B$31.20B$44.14B8.8%100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2025)

Female Infertility
Male Infertility
06667133332000026666

Segment Market Share

  • Female Infertility55%
  • Male Infertility45%

Total Market Size

$44.14B

Market by Segment (2025)

APPLICATIONREVENUE ($B)GROWTH RATEMARKET PENETRATION
Female Infertility$24.24B8.8%
77%
Male Infertility$19.90B8.8%
54%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans
Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Fertility Services Market — Key Findings

Analytical insights on Fertility Services Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Fertility Services Market market is projected to reach $44.14B by 2025, growing at 8.8% CAGR. The Female Infertility segment holds the largest share.

Market Dynamics

Fertility services are procedures or treatments used to cure genetic and fertility issues and assist with conception. These services include assisted reproductive technology (ART) methods and drugs that help single parents, infertile couples, and the lesbian, gay, bisexual, and transgender (LGBT) community in planning a family.

Factors such as declining fertility rate, technological advancements in fertility treatments, growth in the median age of first-time motherhood, and rise in obesity, along with the consumption of alcohol/cigarettes, are leading to infertility which is eventually driving the market for fertility services. However, high procedural costs of assisted reproductive techniques in developed markets and ethical & social concerns related to the ART treatment is hampering the overall growth of the fertility services market.

Likewise, reimbursement for fertility treatment serves as an opportunity for the growth of the market.

Market Drivers

Over the years, fertility services have witnessed high growth due to late marriages, improved contraceptive methods, and the growing number of women prioritizing their careers over starting a family which has also led to the growth in the median age of first-time motherhood. According to Eurostat, the mean age of women in the European Union (EU) on giving birth to their first child has increased from 28.7 in 2013 to 29.1 in 2017. Additionally, according to a report by the United Nations Department of Economics and Social Affairs World Fertility, the average age of first-time pregnancies in women has also risen over the years and was found to be higher in women in their late 20s or early 30s in France. As the median age for first-time motherhood keeps increasing, a growing number of women are expected to face complications in conceiving naturally which also leads to infertility. For instance, according to the National Center for health statistics, in 2015, the fertility rate was 62.5 births per 1,000 women, which dropped by 2% to 60.2 births per 1,000 women in 2017. This downfall in the fertility rate increases the number of women opting for ART treatments, which eventually drives the fertility services market.

Market Opportunities

The growing availability of funding and reimbursement for certain fertility treatments can be a huge opportunity for the market during the assessment period.

According to the data stated by the IVF Worldwide, in Austria, 70% of the treatment and drug costs for IVF/ICSI are reimbursed by IVF-fund in specific indications.Additionally, in Germany, patients up to 40 years of age for 4 IVF or IVF/ICSI cycles or 2 GIFT are reimbursed. Moreover, according to the ESHRE Fact Sheets 2017, Belgium, Denmark, Netherlands, and Slovenia are reputed to have the most generous reimbursement policies in Europe, with almost full coverage for up to six cycles of IVF. In addition, the extent of state support varies from around 90% in Belgium, France, Greece, Netherlands, and Slovenia, to 20 to 30% in Bulgaria, Romania, and Spain.

Hence, reimbursement for fertility treatment serves is expected to pose significant growth opportunities in the fertility services market during the forecast period.

Market Restraints

Despite the growing adoption of fertility treatments, the high cost associated with the fertility treatment is hampering the growth of the market. According to the data mentioned by the Monash IVF Australia, the initial IVF cycle costs approximately USD 3065.22 (AUD 4,461) and subsequent IVF cycle after Medicare safety net costs approximately USD 2676.31 (AUD 3,895). Moreover, according to the CARE Fertility Group Limited (UK), IVF treatments cost USD 3340-3841 (3,000 to 3,450 Euros), Intrauterine Insemination (IUI) costs USD 890-950 (800 to850 Euros), and Intracytoplasmic sperm injection costs USD 1280-1503 (1,150 to 1,350 Euros) in the Europe region. The American Society for Reproductive Medicine (ASRM) lists the average price of an in vitro fertilization (IVF) cycle in the US to be USD 12,400. Thus, the high cost of assisted reproductive techniques to treat infertility is restraining the growth of this market.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2025)

Value (USD Mn)
Female Infertility
Male Infertility

Companies

Key companies profiled in Fertility Services Market

Profiles of 108 companies operating in the Fertility Services Market market, including revenue, employee count, and market positioning where available.

Showing 108 of 108 companies

KITAZATO C

KITAZATO CORPORATION

Healthcare

Company Headquarters: Tokyo, Japan Founded: 1998 Workforce: ~NA Company Working: Kitazato Corporation is engaged in research, development, and manufacture of medical and biotechnological products for human reproduction. Its Cryotop method for vitrification of oocytes and embryos in all stages of development is renowned worldwide. It offers a broad range of products which include ovarian puncture needles, embryo transfer catheters, insemination catheters, and vitrification systems, among others.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1997
Tokyo, Japan
FUJIFILM I

FUJIFILM IRVINE SCIENTIFIC

Healthcare

Company Headquarters: California, US Founded: 1970 Workforce: ~100 Company Working: FUJIFILM Irvine Scientific operated as a subsidiary of Fujifilm Corporation as of June 2018. It is a renowned leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company operates dual cGMP manufacturing facilities in California and Tokyo. It offers a broad range of prenatal, diagnostics, & cytogenetics products, reproductive media products, classical media products, and culture media solutions.

Revenue$20.4B
Employees100
Market CapN/A
Founded1969
California, US
COOK

COOK

Healthcare

Company Headquarters: Bloomington, US Founded: 1963 Workforce: ~12,000* (*- Cook Group) Company Working: Cook operates as a subsidiary of Cook Group. It is engaged in the development, manufacture, and distribution of a broad range of medical devices for healthcare systems. It operates through two business divisions which include medical vascular division and medical medsurg division. The products offered by Cook include urological and gynecological devices, biological materials, endoscopic accessories, cardiac rhythm management, and vascular products. It delivers its products in around 135 countries across geographies.

RevenueN/A
Employees12,000
Market CapN/A
Founded1962
Bloomington, US
MONASH IVF

MONASH IVF GROUP

Healthcare

Company Headquarters: Victoria, Australia Founded: 2014 Workforce: ~650 Company Working: Monash IVF Group is a leading provider of assisted reproductive services in Australia and Malaysia. The company operates through two business segments, which include Monash IVF Group Australia and Monash IVF Group International. Monash IVF Group Australia provides assisted reproductive services, ultrasound, and other related services, while Monash IVF Group International provides assisted reproductive services in Malaysia. It has a network of around 40 IVF clinics, ultrasound practices, and service centers across Australia and Malaysia.

Revenue$0.2B
Employees650
Market CapN/A
Founded2013
Victoria, Australia
VITROLIFE

VITROLIFE

Healthcare

Company Headquarters: Sweden Founded: 1994 Workforce: ~400 Company Working: Vitrolife is renowned as one of the leading providers of IVF laboratories with high-quality products. It offers a broad range of products for the preparation, cultivation, and storage of human cells, tissues, and organs which include needles, pipettes, incubators, and laser & imaging systems, among others. It operates through four business units including media, time-lapse, disposable devices, and art equipment. It runs production facilities in over ten countries worldwide.

Revenue$0.1B
Employees400
Market CapN/A
Founded1993
Sweden
INVO BIOSC

INVO BIOSCIENCE

Healthcare

Company Headquarters: Florida, US Founded: 2007 Workforce: ~N/A Company Working: INVO Bioscience is a major medical device company that offers simplified and low-cost treatments for patients who are diagnosed with infertility. The company is majorly focused on the treatment of infertility through its assisted reproductive technology (ART). INVO is a FDA-approved medical device used for natural in-vivo incubation of eggs and sperms during the fertilization and early embryo development phase which acts as an alternative to traditional Intrauterine Insemination (IUI) and In-Vitro Fertilization (IVF) systems. It has a strong presence across the Americas.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2006
Florida, US
Page 1 of 18
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Fertility Services Market

Starting from
$4,950